Data on diabetes-specific distress are needed to improve the quality of diabetes care - Authors' reply
- PMID: 34090602
- DOI: 10.1016/S0140-6736(21)00664-4
Data on diabetes-specific distress are needed to improve the quality of diabetes care - Authors' reply
Conflict of interest statement
JES reports personal fees from AstraZeneca, Mylan, Boehringer Ingelheim, Sanofi, MSD, Novo Nordisk, Eli Lilly, and Abbott, unrelated to this Correspondence. L-LL reports grants, personal fees, and non-financial support from AstraZeneca, Boehringer Ingelheim, Merck Serono, MSD, Novo Nordisk, Pfizer, Procter and Gamble Health, Sanofi, and Servier, unrelated to this Correspondence. All other authors declare no competing interests.
Comment on
-
Data on diabetes-specific distress are needed to improve the quality of diabetes care.Lancet. 2021 Jun 5;397(10290):2149. doi: 10.1016/S0140-6736(21)00633-4. Lancet. 2021. PMID: 34090601 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical